Cephalon Says Patent Toss Doesn't Bar Pay-For-Delay Defense
Cephalon Inc. told a Pennsylvania federal judge Thursday that it should be allowed to defend a series of pay-for-delay deals it struck with generic-drug competitors over the narcolepsy drug Provigil during...To view the full article, register now.
Already a subscriber? Click here to view full article